logo

For the Inventor, By the Inventor

Madeira, OH, United States of America

Thomas R Blohm

This inventor holds 9 USPTO granted patents, plus 6 CIPO patents. Top assignee: Merrell Dow Pharmaceuticals. Active years: 1990-1995.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Thomas R Blohm. Retrieved from https://idiyas.com/inventor/thomas-r-blohm-fwlnxvhc

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 9

% Patents Active = 100.0

 

Average Co-Inventor Count = 2.5

ph-index = 5

Forward Citations = 159(Granted Patents)


Location History:

  • Cincinnati, OH (US) (1990 - 1991)
  • Maderia, OH (US) (1992)
  • Madeira, OH (US) (1992 - 1995)

Company Filing History:

goldMedal9 out of 455 
 
Merrell Dow Pharmaceuticals
 patents

Years Active: 1990-1995

Loading Chart...
Loading Chart...
9 patents (USPTO):Explore Patents
1. 5436237 - Method of using 4-amino-.DELTA..sup.4 -steroids in the treatment of (1995-07-25),
2. 5318961 - 4-amino-.DELTA.4-steroids and their use as 5.alpha.-reductase inhibitors (1994-06-07),
3. 5143909 - Aminosteroids in a method for inhibiting C17-20 lyase (1992-09-01),
4. 5120840 - 4-amino-4-ene-steroids and their use as 5.alpha.-reductase inhibitors (1992-06-09),
5. 5100917 - Novel A-nor-steroid-3-carboxylic acid derivatives (1992-03-31),
6. 5075464 - 17.beta.-(cyclopropylamino)androstene derivatives (1991-12-24),
7. 4966898 - 4-substituted 17.beta.-(cyclopropylamino)androst-5-en-3.beta.-ol and (1990-10-30),
8. 4966897 - 4-substituted 17.beta.-(cyclopropyloxy)androst-5-en-3.beta.-ol and (1990-10-30),
9. 4891367 - 17.beta.-(cyclopropyloxy)androst-5-en-3.beta.-ol and related compounds (1990-01-02),

Title: **Innovations of Thomas R. Blohm in Pharmaceutical Research**

Introduction

Thomas R. Blohm is an accomplished inventor based in Madeira, Ohio, known for his significant contributions to pharmaceutical research. With a remarkable portfolio of nine patents, his work primarily focuses on the development of innovative compounds that serve as inhibitors in medical treatments.

Latest Patents

Among his latest inventions, Blohm has developed methods for using 4-amino-Δ4-steroids in the treatment of DHT-mediated diseases. His patents detail the preparation of these compounds through the reaction of appropriate 4-azido steroids with triphenylphosphine in an aqueous inert solvent accompanied by heating. Such advancements target the inhibition of 5α-reductase, showcasing Blohm's commitment to addressing serious health conditions.

Career Highlights

Throughout his career, Thomas R. Blohm has been affiliated with Merrell Dow Pharmaceuticals, where he has conducted extensive research and developed groundbreaking pharmaceutical innovations. His dedication to exploring new and effective treatment options has positioned him as a key player within the industry.

Collaborations

Blohm's work has allowed him to collaborate with notable peers, including Michael R. Angelastro and Philip M. Weintraub. These collaborations not only enhance the quality of innovation but also foster a rich environment of shared expertise that propels pharmaceutical advancement.

Conclusion

Thomas R. Blohm exemplifies the spirit of innovation through his dedication to developing effective medications. His contributions in the field of pharmaceutical research have the potential to significantly impact the treatment of diseases, thereby improving the quality of life for many individuals. As he continues his work at Merrell Dow Pharmaceuticals, the pharmaceutical community eagerly anticipates his future inventions.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…